Daniela Salvemini Selected Research

Daniela Salvemini Research Topics

Disease

57	Pain (Aches) 01/2024 - 06/2004
41	Neuralgia (Stump Neuralgia) 01/2024 - 12/2011
33	Hyperalgesia 11/2022 - 06/2004
23	Chronic Pain 10/2021 - 11/2007
21	Inflammation (Inflammations) 01/2023 - 05/2002
13	Hypersensitivity (Allergy) 01/2024 - 09/2008
12	Peripheral Nervous System Diseases (PNS Diseases) 01/2022 - 05/2012
12	Neoplasms (Cancer) 01/2022 - 06/2003
9	Shock 02/2009 - 11/2002
5	Neuroinflammatory Diseases 01/2023 - 07/2013
5	Multiple Sclerosis 01/2023 - 07/2014
5	Body Weight (Weight, Body) 01/2022 - 06/2003
5	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 05/2012
4	Asthma (Bronchial Asthma) 01/2023 - 08/2005
4	Cognitive Dysfunction 01/2022 - 01/2018
4	Edema (Dropsy) 01/2013 - 06/2004
4	Hypotension (Low Blood Pressure) 06/2011 - 01/2003
4	Ischemia 10/2008 - 06/2002
4	Reperfusion Injury 10/2008 - 07/2002
3	Heart Failure 10/2023 - 07/2002
3	Atherosclerosis 07/2019 - 07/2003
3	Wounds and Injuries (Trauma) 01/2018 - 04/2011
3	Necrosis 09/2004 - 05/2002
3	Septic Shock (Toxic Shock Syndrome) 01/2003 - 11/2002
2	Breast Neoplasms (Breast Cancer) 11/2023 - 11/2016
2	Fibrosis (Cirrhosis) 11/2022 - 01/2020
2	Migraine Disorders (Migraine) 10/2021 - 01/2020
2	Headache (Headaches) 10/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

33	Peroxynitrous Acid (Peroxynitrite)IBA 10/2021 - 06/2002
30	Superoxides (Superoxide)IBA 12/2016 - 05/2002
24	Superoxide DismutaseIBA 12/2020 - 06/2002
19	Analgesics (Analgesic Drugs)IBA 11/2023 - 11/2007
18	Opioid Analgesics (Opioids)IBA 01/2024 - 08/2012
16	Purinergic P1 Receptors (Adenosine Receptor)IBA 07/2021 - 05/2012
15	EnzymesIBA 01/2020 - 06/2002
14	Morphine (MS Contin)FDA LinkGeneric 11/2023 - 04/2009
12	CeramidesIBA 09/2017 - 02/2008
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2023 - 06/2002
11	CytokinesIBA 11/2022 - 01/2003
11	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 06/2002
11	imisopasem manganeseIBA 05/2008 - 05/2002
10	Sphingosine-1-Phosphate ReceptorsIBA 11/2022 - 03/2011
10	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 03/2011
10	Adenosine (Adenocard)FDA LinkGeneric 01/2021 - 01/2003
10	CarrageenanIBA 01/2020 - 06/2004
10	Opiate AlkaloidsIBA 07/2013 - 11/2007
9	Fingolimod Hydrochloride (FTY720)FDA Link 01/2022 - 01/2013
7	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2022 - 05/2012
7	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 05/2012
7	Narcotics (Narcotic Analgesics)IBA 07/2021 - 06/2004
7	SphingolipidsIBA 11/2020 - 08/2011
7	3-nitrotyrosineIBA 08/2012 - 08/2002
6	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 07/2021 - 05/2012
6	PorphyrinsIBA 12/2020 - 04/2010
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
5	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 05/2002
5	ProstaglandinsIBA 12/2020 - 02/2008
5	AntioxidantsIBA 12/2020 - 05/2004
5	MRS5698IBA 01/2020 - 12/2014
5	AnionsIBA 01/2015 - 05/2002
5	M40401IBA 10/2004 - 01/2003
4	LigandsIBA 11/2022 - 06/2004
4	Adenosine A3 ReceptorIBA 11/2022 - 01/2015
4	Interleukin-10 (Interleukin 10)IBA 01/2021 - 02/2015
4	Bortezomib (Velcade)FDA Link 01/2020 - 05/2012
4	Oxygen (Dioxygen)IBA 12/2016 - 01/2003
4	NADPH Oxidases (NAD(P)H oxidase)IBA 12/2014 - 07/2003
4	Oxidants (Oxidizing Agents)IBA 08/2012 - 06/2002
3	AcidsIBA 01/2024 - 04/2010
3	ProdrugsIBA 01/2023 - 01/2020
3	Transcription Factors (Transcription Factor)IBA 11/2022 - 08/2004
3	Adenosine KinaseIBA 11/2022 - 01/2015
3	InflammasomesIBA 11/2022 - 11/2020
3	NLR ProteinsIBA 11/2022 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 05/2004
3	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 01/2003
3	Free RadicalsIBA 09/2021 - 06/2003
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2020 - 06/2004
3	OvalbuminIBA 10/2020 - 08/2005
3	Purinergic P1 Receptor AgonistsIBA 01/2017 - 12/2014
3	NitrogenIBA 12/2016 - 10/2010
3	N-Methylaspartate (NMDA)IBA 01/2013 - 05/2002
3	Interleukin-2 (IL2)IBA 06/2011 - 06/2003
3	dihydroceramide desaturaseIBA 02/2009 - 02/2008
3	Ligases (Synthetase)IBA 11/2002 - 06/2002
2	Mitogen-Activated Protein KinasesIBA 01/2024 - 11/2022
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2024 - 11/2022
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2022 - 11/2020
2	SEW2871IBA 11/2022 - 01/2013
2	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 09/2021 - 01/2013
2	Peptides (Polypeptides)IBA 01/2021 - 11/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 12/2014
2	Reactive Nitrogen SpeciesIBA 12/2020 - 11/2016
2	manganese(III)-tetrakis(4-benzoic acid)porphyrinIBA 12/2020 - 01/2009
2	Dinoprostone (PGE2)FDA Link 12/2020 - 08/2011

Therapy/Procedure

24	Therapeutics 01/2024 - 05/2004
15	Drug Therapy (Chemotherapy) 01/2022 - 05/2012
4	Spinal Injections 01/2024 - 01/2013
3	Intraperitoneal Injections 11/2020 - 09/2004
3	Analgesia 12/2016 - 09/2008